Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1327 | 1203 | 1512 | 1692 | 3845 | 5151 |
Fund Return | 32.71% | 20.33% | 51.15% | 19.15% | 30.91% | 17.81% |
Place in category | 72 | 85 | 59 | 28 | 19 | 5 |
% in Category | 89 | 98 | 86 | 37 | 32 | 18 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Reliance Small Cap Fund Bonus | 610B | 30.00 | 32.27 | 24.36 | ||
Reliance Small Cap Fund Dividend | 610B | 29.08 | 33.42 | 24.68 | ||
Reliance Small Cap Fund Growth | 610B | 30.00 | 32.27 | 24.36 | ||
Reliance Small Cap Fund Dir Bon | 610B | 30.69 | 33.42 | 25.56 | ||
Reliance Small Cap Fund Dir Gr | 610B | 29.98 | 34.55 | 25.89 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Reliance Pharma Fund - Bonus | 86.48B | 31.92 | 18.08 | 16.78 | ||
Reliance Pharma Dividend Payout | 86.48B | 30.94 | 19.48 | 17.85 | ||
Reliance Pharma Fund - Growth | 86.48B | 31.92 | 18.08 | 16.78 | ||
Reliance Pharma Direct Growth | 86.48B | 32.71 | 19.15 | 17.81 | ||
Reliance Pharma Dir Div Payout | 86.48B | 32.17 | 20.29 | 18.59 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Sun Pharma | INE044A01036 | 13.81 | 1,948.70 | +2.65% | |
Lupin | INE326A01037 | 8.30 | 2,218.50 | +1.39% | |
Divi's Labs | INE361B01024 | 7.96 | 5,457.90 | +1.46% | |
Cipla | INE059A01026 | 5.93 | 1,672.50 | +3.13% | |
Dr Reddy’s Laboratories | INE089A01023 | 5.69 | 6,749.90 | +0.08% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review